LICATA, MARTINA
LICATA, MARTINA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells
2024 Meanti, R; Rizzi, L; Bresciani, E; Licata, M; Molteni, L; Omeljaniuk, R; Fehrentz, J; Denoyelle, S; Locatelli, V; Torsello, A
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study
2024 Meanti, R; Rizzi, L; Bresciani, E; Licata, M; Molteni, L; Omeljaniuk, R; Fehrentz, J; Denoyelle, S; Locatelli, V; Torsello, A
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study
2024 Meanti, R; Rizzi, L; Bresciani, E; Licata, M; Sartori, E; Omeljaniuk, R; Fehrentz, J; Denoyelle, S; Locatelli, V; Torsello, A
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein
2023 Meanti, R; Licata, M; Rizzi, L; Bresciani, E; Molteni, L; Coco, S; Locatelli, V; Omeljaniuk, R; Torsello, A
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis
2022 Meanti, R; Rizzi, L; Bresciani, E; Licata, M; Molteni, L; Locatelli, V; Torsello, A
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis
2022 Meanti, R; Rizzi, L; Bresciani, E; Licata, M; Molteni, L; Locatelli, V; Torsello, A